Notification of Patent Term Restoration. Each of Dyax and Genzyme shall notify the other Party of (a) the issuance of each United States patent included within the Patent Rights for which the notifying Party is responsible, giving the date of issue and patent number for each such patent, and (b) each notice pertaining to any patent included within the Patent Rights for which the notifying Party is responsible which it receives as patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, including notices pursuant to Sections 101 and 103 of such Act from persons who have filed an abbreviated NDA. Such notices shall be given promptly, but in any event within ten (10) business days after receipt of each such notice pursuant to such Act. Each of Dyax and Genzyme shall notify the other Party of each filing for patent term restoration under such Act, any allegations of failure to show due diligence and all awards of patent term restoration (extensions) with respect to the Patent Rights for which the notifying Party is responsible.
Notification of Patent Term Restoration. Transcend shall notify BI of (a) the issuance of each patent included within the Transcend Patent Rights and the Program Patent Rights, giving the date of issue and patent number for each such patent, and (b) each notice pertaining to any patent included within the Transcend Patent Rights and the Program Patent Rights which it receives as patent term restorations. The Parties shall cooperate with each other in applying for patent term extensions (including Supplementary Protection Certificates in European Community Countries and administrative/pipeline protection) where applicable in any country. Transcend shall also notify BI of each application filed for patent term extension, any allegations of failure to show due diligence and all awards of patent term extensions with respect to the Transcend Patent Rights and the Program Patent Rights. Such notices shall be given promptly, but in any event within ten (10) business days after receipt of each such notice pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (the "Act") (or comparable laws or regulations in countries other than the United States). Transcend shall notify BI of each filing for patent term restoration under the Act (or comparable laws or regulations in countries other than the United States), any allegations of failure to show due diligence and all awards of patent term restoration (extensions) with respect to the Transcend Patent Rights and the Program Patents Rights.
Notification of Patent Term Restoration. Each of Diacrin and Genzyme shall notify the other Party of (i) the issuance of each United States patent included within the notifying Party's Patent Rights, giving the date of issue and patent number for each such patent, and (ii) each notice pertaining to any patent included within the notifying Party's Patent Rights which it receives as patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, including notices pursuant to 101 and 103 of such Act from persons who have filed an abbreviated NDA. Such notices shall be given promptly, but in any event within ten (10) business days after receipt of each such notice pursuant to such Act. Each of Diacrin and Genzyme shall notify the other Party of each filing for patent term restoration under such Act, any allegations of failure to show due diligence and all awards of patent term restoration (extensions) with respect to the notifying Party's Patent Rights.
Notification of Patent Term Restoration. Ixsys or Xxxxxxx-Xxxxx, as the case may be, shall notify the other party of (a) the issuance of each U.S. patent included within the Patent Rights, giving the date of issue and patent number for each such patent, and (b) each notice pertaining to any patent included within the Patent Rights which it receives as patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (hereinafter called the "Act"), including notices pursuant to Paragraphs 101 and 103 of the Act from persons who have filed an abbreviated NDA ("ANDA"). Such notices shall be given promptly, but in any event within five (5) calendar days of each such patent's date of issue or receipt of each such notice pursuant to the Act, whichever is applicable. Ixsys or Xxxxxxx-Xxxxx, as the case may be, shall notify the other party of each filing for patent term restoration under the Act, any allegations of failure to show due diligence and all awards of patent term restoration (extensions) with respect to the Patent Rights. Likewise, Ixsys or Xxxxxxx-Xxxxx, as the case may be, shall inform the other xxxxx of patent extensions and periods of data exclusivity in the rest of the world regarding any Product.
Notification of Patent Term Restoration. The Parties shall cooperate with each other in obtaining patent term restoration or supplemental protection certificates or their equivalents in any country where applicable to the KR Intellectual Property Rights in the MN Territory. MN shall notify KR of (a) the issuance of each U.S. patent included within the KR Intellectual Property Rights, giving the date of issue and patent number for each such patent, and (b) each notice pertaining to any patent included within the KR Intellectual Property Rights pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (the “1984 Act”), including notices pursuant to §§ 101 and 103 of the 1984 Act from Persons who have filed an abbreviated NDA. Such notices shall be given promptly, but in any event within five (5) days of each such patent’s date of issue or receipt of each such notice pursuant to the 1984 Act, whichever is applicable. MN shall notify KR of each filing for patent term restoration under the 1984 Act and all awards of patent term restoration (extensions) with respect to the KR Intellectual Property Rights. Likewise, KR or MN, as the case may be, shall inform the other Party of patent extensions and periods of data exclusivity in the rest of the world regarding any Licensed Product.
Notification of Patent Term Restoration. MTI shall notify Sankyo of (i) the issuance of each United States patent included within the Patent Rights, giving the date of issue and patent number for each such patent, and (ii) each notice pertaining to any patent included within the Patent Rights which it receives as patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (the "Act"), including notices pursuant to Sections 101 and 103 of the Act from persons who have filed an abbreviated NDA. Such notices shall be given promptly, but in any event within fifteen (15) calendar days of each such patent's date of issue or receipt of each such notice pursuant to the Act, whichever is applicable. MTI shall notify Sankyo of each filing for patent term restoration under the Act, any allegations of failure to show due diligence and all awards of patent term restoration (extensions) with respect to the Patent Rights. Likewise, Sankyo will inform MTI of patent extensions and periods of data exclusivity in the rest of the world regarding any Product.
Notification of Patent Term Restoration. The Parties shall cooperate with each other in obtaining patent term restoration or supplemental protection certificates or their equivalents in any country or jurisdiction where applicable to the MS Patent Assets in the MN Territory and the MS Territory. Each Party shall notify the other if it becomes aware of (a) the issuance of a patent included within the MS Patent Assets, giving the date of issue and patent number for each such patent, and (b) each notice pertaining to any patent included within the MS Patent Assets pursuant to the United States Drug Price Competition and Patent Term Restoration Act of 1984 (hereinafter referred to as “1984 Act”), including notices pursuant to §§ 101 and 103 of the 1984 Act from Persons who have filed an ANDA. Such notices shall be given promptly, but in any event within five (5) days of each Party’s becoming aware of such patent’s issue or receipt of each such notice pursuant to the 1984 Act, whichever is applicable. MS shall notify MN of each filing for patent term restoration under the 1984 Act, and all awards of patent term restoration (extensions) with respect to the MS Patent Assets. Likewise, MS or MN, as the case may be, shall inform the other Party of patent extensions and periods of data exclusivity in the rest of the world regarding any Patent Assets included in the MS Patent Assets and MN Patent Assets.
Notification of Patent Term Restoration shall notify *** of (i) the issuance of each patent included within the TKT Patent Rights, giving the date of issue and patent number for each such patent, and (ii) each notice pertaining to any patent included within the TKT Patent Rights which it receives as patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (hereinafter called the "Act"), or other similar laws now or hereafter in effect, or pursuant to comparable laws or regulations in other countries in the MMD Territory. The parties shall cooperate with each other in applying for patent term extensions (including Supplementary Protection Certificates in European Community Countries) where applicable in any country of the MMD territory. *** shall also notify *** of each application filed for patent term extension, any allegations of failure to show due diligence and all awards of patent term extensions with respect to the TKT Patent Rights. Such notices shall be given promptly, but in any event within ten (10) business days after receipt of each such notice pursuant to the Act (or comparable laws or regulations in other countries in the MMD Territory). *** shall notify *** of each filing for patent term restoration under the Act (or comparable laws or
Notification of Patent Term Restoration. CNSI shall notify Allergan of (i) the issuance of each patent included within the CNSI Patent Rights, CNSI Inventions and/or Joint Inventions or Joint Patent Rights for which CNSI is responsible, giving the date of issue and patent number for each such patent, and (ii) each notice pertaining to any patent included within the CNSI Patent Rights, CNSI Inventions and/or Joint Inventions or Joint Patent Rights for which CNSI is responsible which it receives as patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (hereinafter called the "Act"), or other similar laws now or hereinafter in effect, including notices pursuant to Sections 101 and 103 of the Act from persons who have filed an abbreviated NDA ("ANDA"), or pursuant to comparable laws or regulations in other countries. The Parties shall cooperate
Notification of Patent Term Restoration. Each party or its Affiliates shall notify the other party of (a) the issuance of each United States patent included within the Patents, giving the date of issue and patent number for each such patent, and (b) each notice pertaining to any patent included within the Patents which it receives as patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (the "Act"), including notices pursuant to Sections 101 and 103 of the Act from persons who have filed an abbreviated new drug application. Such notices shall be given promptly, but in any event within five days of each such patent's date of issue or receipt of each such notice pursuant to the Act, whichever is applicable. Each party or its Affiliates shall notify the other party of each filing for patent term restoration under the Act, any allegations of failure to show due diligence and all awards of patent term restoration (extensions) with respect to the Patents. Likewise, each party or its Affiliates shall inform the other party of patent extensions and periods of data exclusivity in the rest of the world relating to Products.
